3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Neoplasms
3
Prostatic Neoplasms
2
Pain, Postoperative
2
Pain
2
Neuroma
2
Chronic Pain
2
Breast Diseases
2
Wounds and Injuries
1
Stroke
1
Stomach Neoplasms
1
Spinal Cord Injuries
1
Skin Diseases
1
Rectal Neoplasms
1
Prostatic Hyperplasia
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Muscular Atrophy
1
Muscle Spasticity
1
Lower Urinary Tract Symptoms
1
Low Anterior Resection Syndrome
1
Head and Neck Neoplasms
1
Gastroparesis
1
Ganglion Cysts
1
Esophageal Neoplasms
1
Esophageal Motility Disorders
1
Esophageal Diseases
1
Esophageal Achalasia
1
Cluster Headache
1
Brain Injuries
1
Interventions
Pancreaticoduodenectomy
2
Sulfasalazine
1
Serum Albumin, Human
1
Saline Solution
1
Pyloromyotomy
1
Pancreatectomy
1
Octreotide
1
Endoscopy
1
Botulinum Toxins, Type A
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gastroparesis
×
Botulinum Toxins, Type A
×
Clear all
NCT06721520
2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3
Recruiting
170 enrolled